Valérie Leclair
Karolinska University Hospital
23 Papers
Valérie Leclair is an academic researcher from Karolinska University Hospital. The author has contributed to research in topics: Medicine & Dermatomyositis. The author has an hindex of 5, co-authored 8 publications. Previous affiliations of Valérie Leclair include Jewish General Hospital.
Chat about Author
Papers
Efficacy and safety of rituximab in anti-synthetase antibody positive and negative subjects with idiopathic inflammatory myopathy: a registry-based study.
Valérie Leclair,Valérie Leclair,Angeles Shunashy Galindo-Feria,Maryam Dastmalchi,Marie Holmqvist,Ingrid E. Lundberg +5 more
TL;DR: Irrespectively of their autoantibody status, a majority of subjects treated with several rituximab cycles had moderate/major improvement and in addition, ARS-ab positive subjects experienced a significant glucocorticoid-sparing effect.
30
Scleromyositis: A distinct novel entity within the systemic sclerosis and autoimmune myositis spectrum. Implications for care and pathogenesis
Margherita Giannini,Benjamin Ellezam,Valérie Leclair,Frédéric Lefebvre,Yves Troyanov,Marie Hudson,Jean-Luc Senécal,Bernard Geny,Océane Landon-Cardinal,Alain Meyer +9 more
TL;DR: In this article , the authors performed an in-depth review of the literature with the aim of better delineating scleromyositis, and highlighted that this concept is supported by recent clinical, serological and histopathological findings that have important implications for patient management and understanding of the disease pathophysiology.
Epidemiology of the idiopathic inflammatory myopathies
Thomas Khoo,James B. Lilleker,Bernard Yu-Hor Thong,Valérie Leclair,Janine A. Lamb,Hector Chinoy +5 more
TL;DR: The authors present epidemiological data relating to the idiopathic inflammatory myopathies and summarize the current understanding of the risk factors associated with these conditions, as well as highlighting areas that require further research.
25
Successful Lung Transplantation in a Case of Rapidly Progressive Interstitial Lung Disease Associated with Antimelanoma Differentiation-associated Gene 5 Antibodies.
TL;DR: A 38-year-old white man presenting with a 4-month history of uncharacteristic skin rash, mild muscle weakness, arthralgia, and exertional dyspnea is presented with DM, anti-MDA5 antibodies, and RPILD who successfully underwent a bilateral lung transplantation.
20
Distribution and trajectory of direct and indirect costs of idiopathic inflammatory myopathies.
Valérie Leclair,John Moshtaghi-Svensson,Malin Regardt,Marie Hudson,Ingrid E. Lundberg,Marie Holmqvist +5 more
TL;DR: In this paper, the authors estimate the annual direct and indirect costs associated with Idiopathic Inflammatory Myopathies (IIM) over time, including the pre-diagnostic period.
11